WO2023175477 - TREATMENT OF BREAST CANCER WITH AMCENESTRANT

National phase entry:
Publication Number WO/2023/175477
Publication Date 21.09.2023
International Application No. PCT/IB2023/052408
International Filing Date 13.03.2023
Title **
[English] TREATMENT OF BREAST CANCER WITH AMCENESTRANT
[French] TRAITEMENT DU CANCER DU SEIN AVEC DE L'AMCENESTRANT
Applicants **
SANOFI
Inventors
COHEN, Patrick
DE KERMADEC, Elisabeth
LIU, Qianying
PAUX, Gautier
Priority Data
63/319,373   13.03.2022   US
63/375,108   09.09.2022   US
22315323.0   09.12.2022   EP
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
译文

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2613
EPO Filing, Examination, Granting14733
Japan Filing, Examination, Granting2524
South Korea Filing, Examination, Granting2883
USA Filing, Examination, Granting6740
MasterCard Visa
Total: 29,493

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present disclosure provides methods of treating breast cancer with amcenestrant.[French] La présente divulgation concerne des méthodes de traitement du cancer du sein avec de l'amcenestrant.